Structure-function relationships in calpains

Biochemical Journal

Volumn 447, Issue 3, 2012, Pages 335-351

  Campbell, Robert L ^a   Davies, Peter L ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Calcium binding; Domain structure; Enzyme activation; Inhibitor complex; Proteinase; Proteolysis; X ray crystallography

Indexed keywords

CALPAIN; CALPAIN 1; CALPAIN 2;

AMINO TERMINAL SEQUENCE; BINDING SITE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME MECHANISM; GENE SEQUENCE; HYDROPHOBICITY; IN VIVO STUDY; NOMENCLATURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CALPAIN; ENZYME ACTIVATION; HUMANS; PROTEIN CONFORMATION; PROTEIN ISOFORMS; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TERMINOLOGY AS TOPIC;

EID: 84867270850     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120921     Document Type: Review

References (121)

1. Goll, D. E., Thompson, V. F., Li, H., Wei, W. and Cong, J. (2003) The calpain system. Physiol. Rev. 83, 731-801 (Pubitemid 36828925)
2. Guroff, G. (1964) A neutral, calcium-activated proteinase from the soluble fraction of rat brain. J. Biol. Chem. 239, 149-155
3. 2+. II. Identification of the kinase activating factor as a proteolytic enzyme. Biochemistry 7, 2116-2122
4. 2+-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscle. Biochemistry 15, 2150-2158
5. 2+-activated protease possibly involved in myofibrillar protein turnover. Partial characterization of the purified enzyme. Biochemistry 15, 2159-2167
6. Ishiura, S., Sugita, H., Nonaka, I. and Imahori, K. (1980) Calcium-activated neutral protease. Its localization in the myofibril, especially at the Z-band. J. Biochem. 87, 343-346 (Pubitemid 10138349)
7. 2+-dependent protease (calpain) and its high-molecular-weight endogenous inhibitor (calpastatin). Adv. Enzyme Regul. 19, 407-424
8. Mellgren, S. I. (1980) [Alzheimer-type dementia. Possible relation to hypofunction of the cholinergic central nervous system]. Tidsskr. Nor. Laegeforen. 100, 1355-1356
9. 2+-activated protease. J. Biol. Chem. 257, 12471-12474
10. Ohno, S., Emori, Y., Imajoh, S., Kawasaki, H., Kisaragi, M. and Suzuki, K. (1984) Evolutionary origin of a calcium-dependent protease by fusion of genes for a thiol protease and a calcium-binding protein? Nature 312, 566-570 (Pubitemid 15182291)
11. Sorimachi, H., Imajoh-Ohmi, S., Emori, Y., Kawasaki, H., Ohno, S., Minami, Y. and Suzuki, K. (1989) Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle. J. Biol. Chem. 264, 20106-20111 (Pubitemid 20008132)
12. Dear, N., Matena, K., Vingron, M. and Boehm, T. (1997) A new subfamily of vertebrate calpains lacking a calmodulin-like domain: implications for calpain regulation and evolution. Genomics 45, 175-184 (Pubitemid 27449397)
13. Dear, T. N. and Boehm, T. (2001) Identification and characterization of two novel calpain large subunit genes. Gene 274, 245-252 (Pubitemid 32817142)
14. Croall, D. E. and Ersfeld, K. (2007) The calpains: modular designs and functional diversity. Genome Biol. 8, 218
15. Sorimachi, H., Hata, S. and Ono, Y. (2011) Impact of genetic insights into calpain biology. J. Biochem. 150, 23-37
16. 2+-dependent proteinases (mu-calpain and m-calpain). J. Biol. Chem. 264, 10096-10103
17. Graham-Siegenthaler, K., Gauthier, S., Davies, P. L. and Elce, J. S. (1994) Active recombinant rat calpain II. Bacterially produced large and small subunits associate both in vivo and in vitro. J. Biol. Chem. 269, 30457-30460
18. Kinbara, K., Ishiura, S., Tomioka, S., Sorimachi, H., Jeong, S. Y., Amano, S., Kawasaki, H., Kolmerer, B., Kimura, S., Labeit, S. and Suzuki, K. (1998) Purification of native p94, a muscle-specific calpain, and characterization of its autolysis. Biochem J. 335, 589-596 (Pubitemid 28515412)
19. Ma, H., Fukiage, C., Azuma, M. and Shearer, T. R. (1998) Cloning and expression of mRNA for calpain Lp82 from rat lens: splice variant of p94. Invest. Ophthalmol. Vis. Sci. 39, 454-461 (Pubitemid 28093887)
20. Hata, S., Doi, N., Kitamura, F. and Sorimachi, H. (2007) Stomach-specific calpain, nCL-2/calpain 8, is active without calpain regulatory subunit and oligomerizes through C2-like domains. J. Biol. Chem. 282, 27847-27856 (Pubitemid 47529505)
21. Hata, S., Abe, M., Suzuki, H., Kitamura, F., Toyama-Sorimachi, N., Abe, K., Sakimura, K. and Sorimachi, H. (2010) Calpain 8/nCL-2 and calpain 9/nCL-4 constitute an active protease complex, G-calpain, involved in gastric mucosal defense. PLoS Genet. 6, e1001040
22. Schad, E., Farkas, A., Jekely, G., Tompa, P. and Friedrich, P. (2002) A novel human small subunit of calpains. Biochem. J. 362, 383-388 (Pubitemid 34214480)
23. 2+-dependent protease activity and a novel mode of enzyme activation. EMBO J. 18, 6880-6889
24. Strobl, S., Fernandez-Catalan, C., Braun, M., Huber, R., Masumoto, H., Nakagawa, K., Irie, A., Sorimachi, H., Bourenkow, G., Bartunik, H. et al. (2000) The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc. Natl. Acad. Sci. U.S.A. 97, 588-592 (Pubitemid 30070353)
25. 2+ switch aligns the active site of calpain. Cell 108, 649-660
26. Rawlings, N. D., Barrett, A. J. and Bateman, A. (2012) MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 40, D343-D350
27. Corbalan-Garcia, S. and Gomez-Fernandez, J. C. (2010) The C2 domains of classical and novel PKCs as versatile decoders of membrane signals. Biofactors 36, 1-7
28. 2+-binding domain. J. Biol. Chem. 273, 15879-15882
29. Hanna, R. A., Campbell, R. L. and Davies, P. L. (2008) Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature 456, 409-412
30. Moldoveanu, T., Gehring, K. and Green, D. R. (2008) Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains. Nature 456, 404-408
31. Kretsinger, R. H. (1997) EF-hands embrace. Nat. Struct. Biol. 4, 514-516
32. Ono, Y. and Sorimachi, H. (2012) Calpains: an elaborate proteolytic system. Biochim. Biophys. Acta 1824, 224-236
33. Sorimachi, H. and Suzuki, K. (2001) The structure of calpain. J. Biochem. 129, 653-664 (Pubitemid 32499775)
34. Ravulapalli, R., Campbell, R. L., Gauthier, S. Y., Dhe-Paganon, S. and Davies, P. L. (2009) Distinguishing between calpain heterodimerization and homodimerization. FEBS J. 276, 973-982
35. Kinbara, K., Sorimachi, H., Ishiura, S. and Suzuki, K. (1998) Skeletal muscle-specific calpain, p49: structure and physiological function. Biochem. Pharmacol. 56, 415-420
36. Ravulapalli, R., Diaz, B. G., Campbell, R. L. and Davies, P. L. (2005) Homodimerization of calpain 3 penta-EF-hand domain. Biochem. J. 388, 585-591 (Pubitemid 40839936)
37. Sorimachi, H., Hata, S. and Ono, Y. (2011) Calpain chronicle - an enzyme family under multidisciplinary characterization. Proc. Jpn. Acad. Ser. B 87, 287-327
38. Franco, S. J. and Huttenlocher, A. (2005) Regulating cell migration: calpains make the cut. J. Cell Sci. 118, 3829-3838 (Pubitemid 41410267)
39. Lebart, M. C. and Benyamin, Y. (2006) Calpain involvement in the remodeling of cytoskeletal anchorage complexes. FEBS J. 273, 3415-3426
40. Chan, K. T., Bennin, D. A. and Huttenlocher, A. (2010) Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK). J. Biol. Chem. 285, 11418-11426
41. Wells, A., Huttenlocher, A. and Lauffenburger, D. A. (2005) Calpain proteases in cell adhesion and motility. Int. Rev. Cytol. 245, 1-16
42. Cortesio, C. L., Perrin, B. J., Bennin, D. A. and Huttenlocher, A. (2010) Actin-binding protein-1 interacts with WASp-interacting protein to regulate growth factor-induced dorsal ruffle formation. Mol. Biol. Cell 21, 186-197
43. Brini, M. and Carafoli, E. (2009) Calcium pumps in health and disease. Physiol. Rev. 89, 1341-1378
44. McCall, K. (2010) Genetic control of necrosis - another type of programmed cell death. Curr. Opin. Cell Biol. 22, 882-888
45. Inserte, J., Barrabes, J. A., Hernando, V. and Garcia-Dorado, D. (2009) Orphan targets for reperfusion injury. Cardiovasc. Res. 83, 169-178
46. Bertipaglia, I. and Carafoli, E. (2007) Calpains and human disease. Subcell. Biochem. 45, 29-53
47. Biswas, S., Harris, F., Dennison, S., Singh, J. P. and Phoenix, D. (2005) Calpains: enzymes of vision? Med. Sci. Monit. 11, RA301-RA310 (Pubitemid 41334776)
48. Paquet-Durand, F., Johnson, L. and Ekstrom, P. (2007) Calpain activity in retinal degeneration. J. Neurosci. Res. 85, 693-702 (Pubitemid 46426068)
49. Pietsch, M., Chua, K. C. and Abell, A. D. (2010) Calpains: attractive targets for the development of synthetic inhibitors. Curr. Top. Med. Chem. 10, 270-293
50. Carragher, N. O. (2006) Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr. Pharm. Des. 12, 615-638
51. Donkor, I. O. (2011) Calpain inhibitors: a survey of compounds reported in the patent and scientific literature. Expert Opin. Ther. Pat. 21, 601-636
52. 2+-induced structural changes in rat m-calpain revealed by partial proteolysis. Biochim. Biophys. Acta 1545, 245-254
53. Hata, S., Sorimachi, H., Nakagawa, K., Maeda, T., Abe, K. and Suzuki, K. (2001) Domain II of m-calpain is a Ca2 + -dependent cysteine protease. FEBS Lett. 501, 111-114
54. 2+ binding at two non-EF-hand sites. J. Biol. Chem. 279, 6106-6114
55. Suzuki, K., Emori, Y., Ohno, S., Imahori, S., Kawasaki, H. and Miyake, S. (1986) Structure and function of the small (30K) subunit of calcium-activated neutral protease (CANP). Biomed. Biochim. Acta 45, 1487-1491 (Pubitemid 17018580)
56. Nakagawa, K., Masumoto, H., Sorimachi, H. and Suzuki, K. (2001) Dissociation of m-calpain subunits occurs after autolysis of the N-terminus of the catalytic subunit, and is not required for activation. J. Biochem. 130, 605-611 (Pubitemid 33115526)
57. Alexa, A., Bozoky, Z., Farkas, A., Tompa, P. and Friedrich, P. (2004) Contribution of distinct structural elements to activation of calpain by Ca2+ ions. J. Biol. Chem. 279, 20118-20126 (Pubitemid 38623456)
58. Melloni, E., Averna, M., Salamino, F., Sparatore, B., Minafra, R. and Pontremoli, S. (2000) Acyl-CoA-binding protein is a potent m-calpain activator. J. Biol. Chem. 275, 82-86 (Pubitemid 30038956)
59. Melloni, E., Michetti, M., Salamino, F. and Pontremoli, S. (1998) Molecular and functional properties of a calpain activator protein specific for mu-isoforms. J. Biol. Chem. 273, 12827-12831 (Pubitemid 28246838)
60. Farkas, A., Nardai, G., Csermely, P., Tompa, P. and Friedrich, P. (2004) DUK114, the Drosophila orthologue of bovine brain calpain activator protein, is a molecular chaperone. Biochem. J. 383, 165-170 (Pubitemid 39389462)
61. Yoshizawa, T., Sorimachi, H., Tomioka, S., Ishiura, S. and Suzuki, K. (1995) Calpain dissociates into subunits in the presence of calcium ions. Biochem. Biophys. Res. Commun. 208, 376-383
62. Anagli, J., Vilei, E. M., Molinari, M., Calderara, S. and Carafoli, E. (1996) Purification of active calpain by affinity chromatography on an immobilized peptide inhibitor. Eur. J. Biochem. 241, 948-954 (Pubitemid 26379401)
63. Li, H., Thompson, V. F. and Goll, D. E. (2004) Effects of autolysis on properties of muand m-calpain. Biochim. Biophys. Acta 1691, 91-103 (Pubitemid 38521270)
64. Pal, G. P., Elce, J. S. and Jia, Z. (2001) Dissociation and aggregation of calpain in the presence of calcium. J. Biol. Chem. 276, 47233-47238
65. Glading, A., Bodnar, R. J., Reynolds, I. J., Shiraha, H., Satish, L., Potter, D. A., Blair, H. C. and Wells, A. (2004) Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol. Cell. Biol. 24, 2499-2512 (Pubitemid 38326004)
66. Baki, A., Tompa, P., Alexa, A., Molnar, O. and Friedrich, P. (1996) Autolysis parallels activation of mu-calpain. Biochem. J. 318, 897-901
67. 2+ sensitivity on activation of m-calpain. FEBS Lett. 322, 65-68
68. 2+ requirement, and heterodimer stability in m-calpain. J. Biol. Chem. 272, 11268-11275
69. Suzuki, K., Sorimachi, H., Yoshizawa, T., Kinbara, K. and Ishiura, S. (1995) Calpain: novel family members, activation, and physiologic function. Biol. Chem. Hoppe Seyler 376, 523-529
70. Chou, J. S., Impens, F., Gevaert, K. and Davies, P. L. (2011) m-Calpain activation in vitro does not require autolysis or subunit dissociation. Biochim. Biophys. Acta 1814, 864-872
71. Thompson, V. F., Lawson, K. R., Barlow, J. and Goll, D. E. (2003) Digestion of mu- and m-calpain by trypsin and chymotrypsin. Biochim. Biophys. Acta 1648, 140-153
72. Crawford, C., Willis, A. C. and Gagnon, J. (1987) The effects of autolysis on the structure of chicken calpain II. Biochem. J. 248, 579-588
73. DeMartino, G. N., Huff, C. A. and Croall, D. E. (1986) Autoproteolysis of the small subunit of calcium-dependent protease II activates and regulates protease activity. J. Biol. Chem. 261, 12047-12052 (Pubitemid 17202762)
74. Yoshizawa, T., Sorimachi, H., Tomioka, S., Ishiura, S. and Suzuki, K. (1995) A catalytic subunit of calpain possesses full proteolytic activity. FEBS Lett. 358, 101-103
75. Suzuki, K. and Sorimachi, H. (1998) A novel aspect of calpain activation. FEBS Lett. 433, 1-4 (Pubitemid 28386719)
76. Zhang, W. and Mellgren, R. L. (1996) Calpain subunits remain associated during catalysis. Biochem. Biophys. Res. Commun. 227, 891-896
77. Dutt, P., Arthur, J. S., Croall, D. E. and Elce, J. S. (1998) m-Calpain subunits remain associated in the presence of calcium. FEBS Lett. 436, 367-371 (Pubitemid 28482963)
78. Kitagaki, H., Tomioka, S., Yoshizawa, T., Sorimachi, H., Saido, T. C., Ishiura, S. and Suzuki, K. (2000) Autolysis of calpain large subunit inducing irreversible dissociation of stoichiometric heterodimer of calpain. Biosci. Biotechnol. Biochem. 64, 689-695
79. 2+ -induced conformational changes. Nat. Struct. Biol. 4, 532-538
80. Lin, G. D., Chattopadhyay, D., Maki, M., Wang, K. K., Carson, M., Jin, L., Yuen, P. W., Takano, E., Hatanaka, M., DeLucas, L. J. and Narayana, S. V. (1997) Crystal structure of calcium bound domain VI of calpain at 1.9 Å resolution and its role in enzyme assembly, regulation, and inhibitor binding. Nat. Struct. Biol. 4, 539-547
81. Arthur, J. S., Gauthier, S. and Elce, J. S. (1995) Active site residues in m-calpain: identification by site-directed mutagenesis. FEBS Lett. 368, 397-400
82. Elce, J. S., Hegadorn, C., Gauthier, S., Vince, J. W. and Davies, P. L. (1995) Recombinant calpain II: improved expression systems and production of a C105A active-site mutant for crystallography. Protein Eng. 8, 843-848
83. Davies, P. L., Campbell, R. L. and Moldoveanu, T. (2004) Calpain. In The Handbook of Metalloproteins (Messerschmidt, A., ed.), pp. 489-500, John Wiley & Sons, Chichester
84. Mellgren, R. L. and Huang, X. (2007) Fetuin A stabilizes m-calpain and facilitates plasma membrane repair. J. Biol. Chem. 282, 35868-35877 (Pubitemid 350277142)
85. 2+ requirement of calpain activation. Biochem. Biophys. Res. Commun. 323, 1131-1133
86. Takano, J., Tomioka, M., Tsubuki, S., Higuchi, M., Iwata, N., Itohara, S., Maki, M. and Saido, T. C. (2005) Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J. Biol. Chem. 280, 16175-16184 (Pubitemid 40616744)
87. Higuchi, M., Tomioka, M., Takano, J., Shirotani, K., Iwata, N., Masumoto, H., Maki, M., Itohara, S. and Saido, T. C. (2005) Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J. Biol. Chem. 280, 15229-15237 (Pubitemid 40562879)
88. Rao, M. V., Mohan, P. S., Peterhoff, C. M., Yang, D. S., Schmidt, S. D., Stavrides, P. H., Campbell, J., Chen, Y., Jiang, Y., Paskevich, P. A. et al. (2008) Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression. J. Neurosci. 28, 12241-12254
89. Wang, K. K., Posmantur, R., Nadimpalli, R., Nath, R., Mohan, P., Nixon, R. A., Talanian, R. V., Keegan, M., Herzog, L. and Allen, H. (1998) Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch. Biochem. Biophys. 356, 187-196 (Pubitemid 28387723)
90. Moldoveanu, T., Campbell, R. L., Cuerrier, D. and Davies, P. L. (2004) Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site. J. Mol. Biol. 343, 1313-1326 (Pubitemid 39387829)
91. Cuerrier, D., Moldoveanu, T., Inoue, J., Davies, P. L. and Campbell, R. L. (2006) Calpain inhibition by á -ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography. Biochemistry 45, 7446-7452 (Pubitemid 43894938)
92. Cuerrier, D., Moldoveanu, T., Campbell, R. L., Kelly, J., Yoruk, B., Verhelst, S. H., Greenbaum, D., Bogyo, M. and Davies, P. L. (2007) Development of calpain-specific inactivators by screening of positional scanning epoxide libraries. J. Biol. Chem. 282, 9600-9611 (Pubitemid 47104594)
93. Qian, J., Cuerrier, D., Davies, P. L., Li, Z., Powers, J. C. and Campbell, R. L. (2008) Cocrystal structures of primed side-extending á -ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions. J. Med. Chem. 51, 5264-5270
94. Li, Q., Hanzlik, R. P., Weaver, R. F. and Schonbrunn, E. (2006) Molecular mode of action of a covalently inhibiting peptidomimetic on the human calpain protease core. Biochemistry 45, 701-708 (Pubitemid 43122235)
95. Davis, T. L., Walker, J. R., Finerty, Jr, P. J., Mackenzie, F., Newman, E. M. and Dhe-Paganon, S. (2007) The crystal structures of human calpains 1 and 9 imply diverse mechanisms of action and auto-inhibition. J. Mol. Biol. 366, 216-229 (Pubitemid 46123340)
96. Abell, A. D., Jones, M. A., Coxon, J. M., Morton, J. D., Aitken, S. G., McNabb, S. B., Lee, H. Y., Mehrtens, J. M., Alexander, N. A., Stuart, B. G. et al. (2009) Molecular modeling, synthesis, and biological evaluation of macrocyclic calpain inhibitors. Angew. Chem., Int. Ed. Engl. 48, 1455-1458
97. Turk, B. E., Huang, L. L., Piro, E. T. and Cantley, L. C. (2001) Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat. Biotechnol. 19, 661-667 (Pubitemid 32625438)
98. Cuerrier, D., Moldoveanu, T. and Davies, P. L. (2005) Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: the importance of primed side interactions. J. Biol. Chem. 280, 40632-40641 (Pubitemid 41780554)
99. Moldoveanu, T., Hosfield, C. M., Lim, D., Jia, Z. and Davies, P. L. (2003) Calpain silencing by a reversible intrinsic mechanism. Nat. Struct. Biol. 10, 371-378 (Pubitemid 36523272)
100. Elce, J. S. (2000) Expression of m-calpain in Escherichia coli. Methods Mol. Biol. 144, 47-54
101. Masumoto, H., Yoshizawa, T., Sorimachi, H., Nishino, T., Ishiura, S. and Suzuki, K. (1998) Overexpression, purification, and characterization of human m-calpain and its active site mutant, m-C105S-calpain, using a baculovirus expression system. J. Biochem. 124, 957-961 (Pubitemid 28544906)
102. Hata, S., Ueno, M., Kitamura, F. and Sorimachi, H. (2012) Efficient expression and purification of recombinant human m-calpain using an Escherichia coli expression system at low temperature. J. Biochem. 151, 417-422
103. Pal, G. P., De Veyra, T., Elce, J. S. and Jia, Z. (2003) Crystal structure of a micro-like calpain reveals a partially activated conformation with low Ca2+ requirement. Structure 11, 1521-1526 (Pubitemid 37510351)
104. Diaz, B. G., Moldoveanu, T., Kuiper, M. J., Campbell, R. L. and Davies, P. L. (2004) Insertion sequence 1 of muscle-specific calpain, p94, acts as an internal propeptide. J. Biol. Chem. 279, 27656-27666 (Pubitemid 38812607)
105. Wendt, A., Thompson, V. F. and Goll, D. E. (2004) Interaction of calpastatin with calpain: a review. Biol. Chem. 385, 465-472 (Pubitemid 38967773)
106. Hanna, R. A., Garcia-Diaz, B. E. and Davies, P. L. (2007) Calpastatin simultaneously binds four calpains with different kinetic constants. FEBS Lett. 581, 2894-2898 (Pubitemid 46899031)
107. Kiss, R., Kovacs, D., Tompa, P. and Perczel, A. (2008) Local structural preferences of calpastatin, the intrinsically unstructured protein inhibitor of calpain. Biochemistry 47, 6936-6945 (Pubitemid 351898948)
108. Ishima, R., Tamura, A., Akasaka, K., Hamaguchi, K., Makino, K., Murachi, T., Hatanaka, M. and Maki, M. (1991) Structure of the active 27-residue fragment of human calpastatin. FEBS Lett. 294, 64-66
109. Betts, R. and Anagli, J. (2004) The β- and γ-CH2 of B27-WT's Leu11 and Ile18 side chains play a direct role in calpain inhibition. Biochemistry 43, 2596-2604 (Pubitemid 38327855)
110. Betts, R., Weinsheimer, S., Blouse, G. E. and Anagli, J. (2003) Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT. J. Biol. Chem. 278, 7800-7809 (Pubitemid 36800513)
111. Todd, B., Moore, D., Deivanayagam, C. C., Lin, G. D., Chattopadhyay, D., Maki, M., Wang, K. K. and Narayana, S. V. (2003) A structural model for the inhibition of by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor. J. Mol. Biol. 328, 131-146 (Pubitemid 36390286)
112. Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C. et al. (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81, 27-40
113. Hayashi, C., Ono, Y., Doi, N., Kitamura, F., Tagami, M., Mineki, R., Arai, T., Taguchi, H., Yanagida, M., Hirner, S. et al. (2008) Multiple molecular interactions implicate the connectin/titin N2A region as a modulating scaffold for p94/calpain 3 activity in skeletal muscle. J. Biol. Chem. 283, 14801-14814
114. Sorimachi, H., Toyama-Sorimachi, N., Saido, T. C., Kawasaki, H., Sugita, H., Miyasaka, M., Arahata, K., Ishiura, S. and Suzuki, K. (1993) Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J. Biol. Chem. 268, 10593-10605 (Pubitemid 23150250)
115. 2+ -dependent intramolecular autolysis. FEBS Lett. 532, 401-406
116. +-dependent protease. J. Biol. Chem. 285, 22986-22998
117. Jia, Z., Petrounevitch, V., Wong, A., Moldoveanu, T., Davies, P. L., Elce, J. S. and Beckmann, J. S. (2001) Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain. Biophys. J. 80, 2590-2596 (Pubitemid 32521635)
118. Garnham, C. P., Hanna, R. A., Chou, J. S., Low, K. E., Gourlay, K., Campbell, R. L., Beckmann, J. S. and Davies, P. L. (2009) Limb-girdle muscular dystrophy type 2A can result from accelerated autoproteolytic inactivation of calpain 3. Biochemistry 48, 3457-3467
119. 2+-regulated phospholipid-binding domain. Biochem. Biophys. Res. Commun. 280, 1333-1339
120. Ravulapalli, R. (2009) Regulatory domains of the human calpain family. Ph.D. Thesis, Department of Biochemistry, Queen's University, Kingston, Canada
121. 2+ reveals a novel domain association. Biochemistry 46, 13041-13048